22. Risk factor of giant coronary artery aneurysms in Kawasaki disease
Main Article Content
Abstract
This prospective observation study was to analyze the risk factors for giant coronary artery aneurysms in 545 patients diagnosed with Kawasaki diseas at Vietnam National Children's Hospital. The research results notes that among 545 patients incluced in the study, 38 patients had giant coronary artery aneurysm (7%). The average age of study group was 16.4 months old, the ratio male/female Kawasaki patients approximates 1.5/1. Most patients diagnosed with Giant coronary artery aneurysms were under 12 months old. They had higher percentage of white blood cell, lower serum albumin level (which is statistically significant differences between two groups (p < 0.05)). Incomplete Kawasaki disease, late IVIG infusion after 10 days and IVIG resistance were independent predictors of giant coronary artery aneurysms in Kawasaki disease.
Article Details
Keywords
Kawasaki disease, Giant corocary artery aneurysms
References
2. Newburger JW, Takahashi M, Burns JC. Kawasaki Disease. Journal of the American College of Cardiology. 2016;67(14):1738-1749.
3. McCrindle BW, Manlhiot C, Newburger JW, et al. Medium-term complications associated with coronary artery aneurysms after Kawasaki disease: A study from the international Kawasaki disease registry. J Am Heart Assoc. 2020;9(15):e016440.
4. Davies S, Sutton N, Blackstock S, et al. Predicting IVIG resistance in UK Kawasaki disease. Archives of Disease in Childhood. 2015;100(4):366-368.
5. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17).
6. Masuda H, Ae R, Koshimizu T aki, et al. Epidemiology and risk factors for giant coronary artery aneurysms identified after acute Kawasaki disease. Pediatric Cardiology. 2021;42.
7. Ha S, Seo GH, Kim KY, Kim DS, et al. Epidemiologic study on Kawasaki disease in Korea, 2007-2014: Based on health insurance review & assessment service claims. J Korean Med Sci. 2016;31(9):1445-1449.
8. Garrido-García L, Moran E, Yamazaki-Nakashimada M, et al. Giant coronary artery aneurysms complicating Kawasaki disease in Mexican children. Cardiology in the young. 2017;28:1-5.
9. Dietz SM, Kuipers IM, Tacke CEA, et al. Giant aneurysms: A gender-specific complication of Kawasaki disease? Journal of Cardiology. 2017;70(4):359-365.
10. Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. Journal of Epidemiology. Published online February 4, 2012:1201310285-1201310285.
11. Sudo D, Monobe Y, Yashiro M, et al. Case-control study of giant coronary aneurysms due to Kawasaki disease: The 19th nationwide survey. Pediatrics International. 2010;52(5):790-794.
12. Kawasaki T. Kawasaki disease. Proc Jpn Acad Ser B Phys Biol Sci. 2006;82(2):59-71. Accessed May 1, 2021.
13. Yan F, Zhang H, Xiong R, et al. Effect of early intravenous immunoglobulin therapy in Kawasaki disease: A systematic review and meta-analysis. Frontiers in Pediatrics. 2020;8. Accessed September 11, 2022.
14. Shaojie Chen, Ying Dong, Marcio Gk, et al. Coronary artery complication in Kawasaki disease and the importance of early interventation: A system review and meta-analysis. JAMA Pediatr. 2016 Dec 1;170(12):1156-1163. doi: 10.1001/jamapediatrics.2016.2055.
15. Nakamura Y, Yashiro M, Uehara R, et al. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatrics International. 2004;46(1):33-38.